RSS Feeds
Search

Companies

Companies

Displaying 1..10 of 17 - per page Next page
Order by
Profiled on medicaldevicelicensing.com Innocoll, Inc.
Specialty pharmaceutical and drug delivery company engaged in the research and manufacture of collagen-based technologies for local drug delivery, surgical implants, advanced wound care and oncology. More
Profiled on medicaldevicelicensing.com LEIRAS: A TAKEDA company in Northern Europe region
NYCOMED Regional Business Development, new; near to market presciption drugs for region Northern Europe More
Decision Resources Inc.
The worldwide leader in market research publications, advisory services and consulting More
BiotechEast Co., Ltd. (Technology Partner)
BiotechEast is a one-stop, full-service marketing consultancy for those looking to take advantage of the dynamic opportunities in Taiwan's burgeoning life science industry. More
GP Pharm SA
Pharmaceutical company with high value added products for Urology and Oncology based in propietary Drug Delivery Systems. Contract manufacturing of high potency and cytotoxic injectable forms. More
Active Biotech
Active Biotech AB is a Swedish biotech company focusing on the research and development of pharmaceuticals, primarily for the treatment of autoimmune / inflammatory diseases and cancer. More
GOODLIFE Healthcare
GOODLIFE Healthcare is involved primarily in the production of medicines for disorders of endocrinology, urology and gynaecology. More
Dar Al Dawa
Dar Al Dawa is a generic manufacturing company in the Middle East. More
Valera Pharmaceuticals
Valera is a specialty pharmaceutical company focusing on Drug Delivery and Products in Urology, Oncology and Endocrinology More
Pierre Fabre SA
The Pierre Fabre Group, the second-largest independent laboratory in France, employs about 9,300 people and achieved sales of 1.47 billion euros in 2004. More
Displaying 1..10 of 17 - per page Next page
Order by

Related Reports

Market Research Reports provided by reports.innovaro.com
Prostate Cancer Drug Discoveries: What the Future Holds
Nov 2009 - 160 pages - $2,265
Jevtana (Cabazitaxel) - Positive Recommendation in the EU for Metastatic Castration-Resistant Prostate Cancer
Mar 2011 - 5 pages - $500
FDA Approves Zytiga (Abiraterone Acetate) for the Second-Line Treatment of Metastatic Castration-Resistant Prostate Cancer
May 2011 - 5 pages - $500
Epidemiology: Prostate Cancer – Incidence and prevalence reaches new heights due to testing, risk factors, and an aging population
Mar 2011 - 34 pages - $5,700
Endothelin A Receptor Antagonist (atrasentan) Fails to Demonstrate an Advantage in the Treatment of Advanced Prostate Cancer
May 2011 - 5 pages - $500
Clinical Trial Endpoints in Oncology - Inclusion of Surrogate Endpoints and Shorter Endpoints Will Ensure Faster Clinical Trials in Oncology
Mar 2011 - 120 pages - $3,500
Company Financials: Cougar Biotechnology, Inc.
Jan 2010 - $75
Prostate Cancer Therapy Area Pipeline Report
Nov 2010 - 1011 pages - $1,495
US Oncology, Inc. - SWOT Analysis
Nov 2010 - 26 pages - $125
Hormone Refractory Prostate Cancer - Pipeline Review, Q4 2010
Nov 2010 - 50 pages - $500
More Related Market Research Reports >>>

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2012 Innovaro Europe Ltd Innovaro Corporation All rights reserved. Terms and Conditions | Contact us